Department of Medicine, University of Tabuk, Tabuk, Saudi Arabia.
Department of Medicine, Division of Nephrology, Washington University in St. Louis, St. Louis, MO.
Crit Care Med. 2019 Feb;47(2):e74-e80. doi: 10.1097/CCM.0000000000003508.
Acute kidney injury requiring renal replacement therapy is associated with high morbidity and mortality. Complications of renal replacement therapy include hemodynamic instability with ensuing shortened treatments, inadequate ultrafiltration, and delay in renal recovery. Studies have shown that lowering dialysate temperature in patients with end-stage renal disease is associated with a decrease in the frequency of intradialytic hypotension. However, data regarding mitigation of hypotension by lowering dialysate temperature in patients with acute kidney injury are scarce. We conducted a prospective, randomized, cross-over pilot study to evaluate the effect of lower dialysate temperature on hemodynamic status of critically ill patients with acute kidney injury during prolonged intermittent renal replacement therapy.
Single-center prospective, randomized, cross-over study.
ICUs and a step down unit in a tertiary referral center.
Acute kidney injury patients undergoing prolonged intermittent renal replacement therapy.
Participants were randomized to start prolonged intermittent renal replacement therapy with dialysate temperature of 35°C or dialysate temperature of 37°C.
The primary endpoint was the number of hypotensive events, as defined by any of the following: decrease in systolic blood pressure greater than or equal to 20 mm Hg, decrease in mean arterial pressure greater than or equal to 10 mm Hg, decrease in ultrafiltration, or increase in vasopressor requirements. The number of events was analyzed by Poisson regression and other outcomes with repeated-measures analysis of variance. Twenty-one patients underwent a total of 78 prolonged intermittent renal replacement therapy sessions, 39 in each arm. The number of hypotensive events was twice as high during treatments with dialysate temperature of 37°C, compared with treatments with the cooler dialysate (1.49 ± 1.12 vs 0.72 ± 0.69; incidence rate ratio, 2.06; p ≤ 0.0001). Treatment sessions with cooler dialysate were more likely to reach prescribed ultrafiltration targets.
Patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy with cooler dialysate experienced significantly less hypotension during treatment. Prevention of hemodynamic instability during renal replacement therapy helped to achieve ultrafiltration goals and may help to prevent volume overload in critically ill patients.
需要肾脏替代治疗的急性肾损伤与高发病率和死亡率相关。肾脏替代治疗的并发症包括血流动力学不稳定,从而导致治疗时间缩短、超滤不足以及肾功能恢复延迟。研究表明,降低终末期肾病患者透析液温度可降低透析中低血压的频率。然而,关于降低急性肾损伤患者透析液温度以减轻低血压的数据很少。我们进行了一项前瞻性、随机、交叉先导研究,以评估在长时间间歇性肾脏替代治疗期间,降低透析液温度对急性肾损伤危重症患者血流动力学状态的影响。
单中心前瞻性、随机、交叉研究。
三级转诊中心的 ICU 和下一个病房单元。
接受长时间间歇性肾脏替代治疗的急性肾损伤患者。
参与者被随机分配开始长时间间歇性肾脏替代治疗,透析液温度为 35°C 或 37°C。
主要终点是低血压事件的数量,定义为以下任何一种情况:收缩压下降≥20mmHg,平均动脉压下降≥10mmHg,超滤减少或血管加压药需求增加。通过泊松回归分析事件数量,其他结果通过重复测量方差分析进行分析。21 名患者共进行了 78 次长时间间歇性肾脏替代治疗,每个治疗组 39 次。与使用较冷透析液的治疗相比,使用 37°C 透析液的治疗中低血压事件的数量增加了一倍(1.49±1.12 比 0.72±0.69;发生率比,2.06;p≤0.0001)。使用较冷透析液的治疗更有可能达到规定的超滤目标。
接受长时间间歇性肾脏替代治疗的急性肾损伤患者使用较冷的透析液时,治疗期间低血压明显减少。肾脏替代治疗期间血流动力学不稳定的预防有助于达到超滤目标,并可能有助于防止危重症患者的容量超负荷。